Bay Street News, 2024

– ATH434 shows promise as a disease-modifying therapy for MSA – – ATH434-202 Phase 2 interim data demonstrate stabilization of […]

HOUSTON, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”) today announced the […]

PURCHASE, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company […]

MONTREAL, Oct. 02, 2024 (GLOBE NEWSWIRE) — Yorbeau Resources Inc. (TSX: YRB) (the “Company” or “Yorbeau”) is pleased to announce […]

TORONTO, Ontario, Oct. 02, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) announces that following its […]

SASKATOON, Saskatchewan, Oct. 02, 2024 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to […]

VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) — Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: […]

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF | FRA: Z36) (“CLM” […]

ROUYN-NORANDA, Quebec, Oct. 02, 2024 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB: ABMBF) is […]

GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a […]